A Study of Isoquercetin in People With Ovarian Cancer

A Study of Isoquercetin in People With Ovarian Cancer
Conditions: Ovarian Cancer; Epithelial Ovarian Cancer; Serous Ovarian Tumor

Interventions: Drug: Isoquercetin; Other: Placebo

Sponsors: Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH)

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 27, 2025Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments